We are live on
!
Find out more
ZVSAW
ZyVersa Therapeutics, Inc. Warrants
ZVSAW
ZVSAW
Delisted
ZVSAW was delisted on the 20th of December, 2022.
16 hedge funds and large institutions have $1.84M invested in ZyVersa Therapeutics, Inc. Warrants in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
11% less capital invested
Capital invested by funds: $2.07M → $1.84M (-$230K)
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$95K |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$35.5K |
| 3 |
D.E. Shaw & Co
New York
|
+$30.4K |
| 4 |
CS
Clear Street
New York
|
+$25.5K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$261 |
Top Sellers
| 1 |
CM
Cohanzick Management
Pleasantville,
New York
|
-$90K |
| 2 |
RA
RiverPark Advisors
New York
|
-$90K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$721 |
